News

AnaptysBio to Engage Investors in Upcoming Healthcare Events

AnaptysBio to Engage Investors in Upcoming Healthcare Events

Upcoming Investor Conferences for AnaptysBio

As a prominent player in the biotechnology field, AnaptysBio, Inc. (Nasdaq: ANAB) is focused on developing innovative therapeutics that target autoimmune and inflammatory diseases. Based in San Diego, this clinical-stage company has exciting days ahead as it prepares to engage with investors through a series of high-profile conferences this November and December.

Details on the Conferences

The company has announced participation in several key investor conferences where investors can gain insights into AnaptysBio's development programs and future direction. Here's a closer look at these important events:

Guggenheim's Inaugural Healthcare Innovation Conference

This conference in Boston, MA, is scheduled for November 13. AnaptysBio will be featured in a fireside chat format, which will include one-on-one meetings with investors. This is a fantastic opportunity for stakeholders to learn more about the company's current projects and investment potential.

Stifel 2024 Healthcare Conference

Following the Guggenheim event, AnaptysBio will participate in the Stifel 2024 Healthcare Conference on November 19 in New York, NY. In this setting, attendees can anticipate engaging discussions about the company's strategic vision and therapeutic advancements.

Piper Sandler 36th Annual Healthcare Conference

On December 3, AnaptysBio will take part in the Piper Sandler conference, once again in New York. This annual event gathers industry leaders and investors, providing an ideal platform for AnaptysBio to discuss its ongoing projects and innovations.

Evercore HealthCONx Conference

The final conference of the season for AnaptysBio will be the 7th Annual Evercore HealthCONx Conference in Coral Gables, FL, scheduled for December 4. This event will round off their conference participation, and opportunities for networking with investors will abound.

Webcast Availability

For investors who cannot attend these conferences in person, live webcasts of the fireside chats will be available in the investor section of AnaptysBio's website. Replays of these webcasts will also be accessible for at least 30 days after the events, ensuring that all interested parties have the chance to benefit from the discussions.

About AnaptysBio

AnaptysBio is not just about attending conferences; they are at the forefront of developing groundbreaking therapeutics. Their pipeline includes notable programs like ANB032, targeting BTLA receptors, which is currently under scrutiny in a Phase 2b trial aimed at treating atopic dermatitis. Furthermore, their PD-1 agonist, rosnilimab, is being tested in conjunction with Phase 2b and Phase 2 trials aimed at addressing rheumatoid arthritis and ulcerative colitis respectively. As they continue to innovate, AnaptysBio is also advancing other candidates, such as ANB033 and ANB101, which address critical healthcare needs.

Apart from therapeutic antibodies, AnaptysBio has also developed cytokine antagonists that are ready for out-licensing, including imsidolimab and etokimab, both of which have completed or are nearing completion of important clinical trials. In collaboration with GSK, AnaptysBio has made strides in the immuno-oncology field, showcasing their commitment to providing cutting-edge healthcare solutions.

Contact Information

For more information about AnaptysBio and its innovative projects, interested parties can reach out to:

Nick Montemarano
Senior Director, Investor Relations and Strategic Communications
Phone: 858.732.0178
Email: investors@anaptysbio.com

Frequently Asked Questions

What conferences is AnaptysBio participating in?

AnaptysBio is participating in several conferences, including Guggenheim's Healthcare Innovation Conference, Stifel 2024 Healthcare Conference, Piper Sandler Healthcare Conference, and Evercore HealthCONx Conference.

Where can I watch the presentations?

Live webcasts of the presentations will be available on AnaptysBio's investor website, with replays accessible for 30 days after the events.

What is AnaptysBio focusing on?

AnaptysBio is focused on developing innovative immunology therapeutics for autoimmune and inflammatory diseases.

What are some products in AnaptysBio's pipeline?

Some notable products in AnaptysBio's pipeline include ANB032, a BTLA agonist, and rosnilimab, a PD-1 agonist for various inflammatory conditions.

How can I contact AnaptysBio for more information?

You can contact Nick Montemarano at 858.732.0178 or via email at investors@anaptysbio.com for inquiries regarding the company.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ontario Fuels Life Sciences Growth with $1.7M Boost

Updated Category News Views 2

A Jolt for Ontario's Life Sciences Sector Ah, there's fresh energy in the air up north, folks. Ontario's dishing out a solid $1.7 million to give Piramal Pharma Solutions' Aurora facility a serious facelift. This isn't just about shiny new labs. It's about staking a claim, saying, "We're serious players on the global stage." They're not just upgrading infrastructure...

Continue Reading
Survey Says 92% Report Better Life Post-Rehab

Updated Category News Views 3

92% Say Life Improves After TranquilHearts' Treatment It's not every day you see 92% of folks claiming something actually worked for them, huh? That's exactly the kind of figure TranquilHearts Rehab's alumni claimed in their recent survey about improved quality of life post-treatment. But let's not get ahead of ourselves with high-fives and celebration just yet. Here's...

Continue Reading
Sarwant Singh Propels Frost & Sullivan's AI Ambitions

Updated Category News Views 2

A Veteran Strategist Returns to the Fold Sharp moves in the corporate world don't always grab headlines, but sometimes you’ve got to stop and consider the buzzworthy comebacks. Keep your eyes peeled for Sarwant Singh's return to Frost & Sullivan, a noteworthy shift that’s shaping the landscape of digital strategies and beyond. Turning Up the Heat on Digital Innovation...

Continue Reading
Alta's SoMi Walk: Luxury Student Housing on Sale

Updated Category News Views 2

Eyeing the Future in South Miami Real Estate Well, folks, things are heating up in South Miami’s real estate scene, and it’s not something investors want to snooze through. Alta Development, with its decades-long track record, has hurled SoMi Walk into the market ring. This isn't just another dime-a-dozen project. It's a behemoth—standing at 16 stories and posing as...

Continue Reading
Caracal's New Baltimore Hub: A Green Leap in Healthcare

Updated Category News Views 3

Recycling Revolution: Caracal's Bold Move in Baltimore In a world drowning in waste, Caracal Products & Services is making a stand—this time in Baltimore. This latest venture isn't just another warehouse on the map; it’s a beacon for sustainable practices in healthcare recycling. An industrial complex at 2-6 Alco Place now houses Caracal's 9,000-square-foot hub, a...

Continue Reading
Bryan Park's Vision Drives Footprints' Surging Growth

Updated Category News Views 3

An Airman’s Mission of Building Legacies When you think of flooring, 'admired CEOs' probably don’t top the list. Yet here’s Bryan Park, an ex-Air Force veteran, shaking things up and earning a nod from the Denver Business Journal. Named one of the Most Admired CEOs of 2026, Park has taken what began as a small flooring operation and turned it into a national...

Continue Reading
Joe Richardson's Impact Reaches New Heights in 2026

Updated Category News Views 3

They don't hand out "Attorney of the Year" awards to just anyone. Joe Richardson snagged this title from the Richard T. Fields Bar Association not just because he's part of McCune Law Group, but because he's been shaking up the legal arena with his advocacy and leadership. Let's peel back why this matters not only within his circles but for the broader legal community...

Continue Reading
El Mansouri Becomes Morocco's First Female PM

Updated Category News Views 3

Breaking Barriers: El Mansouri's Historic Appointment Fatima Ezzahra El Mansouri is now steering the ship as Morocco's first female Prime Minister, a milestone that's taken far too long to reach. After the dust settled from the September 23 legislative elections, El Mansouri emerged from the Authenticity and Modernity Party (PAM) with 97 seats in tow. It's a pivotal...

Continue Reading
Pathology Ventures: Industry Veteran Takes the Helm

Updated Category News Views 3

What's Brewing with Pathology Ventures? Amidst the bustling landscape of healthcare, Pathology Ventures, LLC shakes things up by appointing Dominic Stockey as their Executive Vice President. Now, buckle up because Stockey isn’t your average Joe. He’s kicking it up a notch by spearheading sponsor and industry partnerships at this physician-founded network. His turf?...

Continue Reading
Oak Farms Invests in Texas Schools and Students

Updated Category News Views 4

Putting Money Where Their Roots Are You have to hand it to Oak Farms; when they say they're rooted in Texas, they actually back it up with some cold, hard cash. They've lined up $27,500 for schools and students across the state. That's the kind of talking I like to see—straight from the brand to the community ledger. No fluff, just good old-fashioned giving in the form...

Continue Reading

Top 5 Most Recently Viewed Articles

Dr. Steinbrech Highlights 2025's Most Coveted Male Looks

Updated Category News Views 157

Exploring Modern Masculinity through Aesthetic Trends In today's world, the perception of masculinity is evolving rapidly. Dr. Douglas S. Steinbrech, a premier plastic surgeon known for his focus on male aesthetics, has compiled an insightful list entitled Top 10 Most Requested Male Faces of 2025. This compilation is more than just a list; it reflects deeper societal...

Continue Reading
Consilio Unveils Guided AI PrivDetect for Efficient Legal Review

Updated Category News Views 273

Consilio Launches Guided AI PrivDetect for Legal Teams Consilio, known as a leader in legal technology solutions, has introduced its latest innovation, Guided AI PrivDetect. This state-of-the-art privilege detection solution merges artificial intelligence with knowledge graph technology, designed to significantly speed up and refine the accuracy of privilege reviews....

Continue Reading
Aulos Bioscience Advances Cancer Treatment with New Trials

Updated Category News Views 132

Aulos Bioscience Advances Cancer Treatment with Innovative Trials Aulos Bioscience, a leader in immuno-oncology, has commenced a promising Phase 2 clinical trial involving AU-007 in combination with avelumab, aimed specifically at tackling non-small cell lung cancer (NSCLC). This collaboration with Ares Trading S.A., a subsidiary of Merck KGaA, focuses on evaluating this...

Continue Reading
Exploring the Future of Heavy Rare Earth Elements in Europe

Updated Category News Views 304

Leading Edge Materials' Norra Kärr HREE Project Update Leading Edge Materials Corp. is making significant advancements in its fully owned Norra Kärr Heavy Rare Earth Elements (HREE) Project. This ambitious initiative aims to extract critical materials crucial for various industries, including technology and energy. With a strategic focus on the sustainable development...

Continue Reading
Discover How $100 in Verisk Analytics Will Grow Over Time

Updated Category News Views 129

Verisk Analytics: A Long-Term Investment Champion Verisk Analytics (NASDAQ: VRSK) has demonstrated remarkable growth over the past 15 years, outpacing the market by an impressive 3.08% annually. Currently, the company boasts a market capitalization of approximately $34.93 billion, underscoring its status as a leader in its field. The Impact of Compound Returns Imagine if...

Continue Reading